Author: Cochran R.C. Formoli T.A. Pfeifer K.F. Aldous C.N.
Publisher: Academic Press
ISSN: 0273-2300
Source: Regulatory Toxicology and Pharmacology, Vol.25, Iss.2, 1997-04, pp. : 146-157
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The cerebrovascular risks associated with tamoxifen use
Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. :
Risks associated with the therapeutic use of fluoroquinolones
By Stahlmann Ralf Lode Hartmut M
Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. :
Potential Risks Associated with the Use of Herbal Anti-Obesity Products
Drug Safety, Vol. 32, Iss. 6, 2009-05 ,pp. :
Off-label use of topiramate to assist with weight loss is associated with serious risks
Reactions Weekly, Vol. 1, Iss. 1373, 2011-01 ,pp. :
Evaluation of Risks Related to the Use of Adeno-Associated Virus-Based Vectors
Current Gene Therapy, Vol. 3, Iss. 6, 2003-12 ,pp. :